Literature DB >> 12004226

The application of percutaneous endoscopic colostomy to the management of obstructed defecation.

A G Heriot1, H S Tilney, J N L Simson.   

Abstract

PURPOSE: We describe the case of a 52-year woman with a 17-year history of obstructed defecation in whom all other standard treatments had failed and the patient had refused a colostomy. Her symptoms were controlled by percutaneous endoscopic colostomy with antegrade colonic irrigation.
METHOD: A percutaneous endoscopic colostomy tube was placed in the sigmoid colon endoscopically using a colonoscope and the patient irrigated two liters of water through the percutaneous endoscopic colostomy twice each day and was able to successfully evacuate her rectum without excess straining or discomfort.
CONCLUSION: Percutaneous endoscopic colostomy is an alternative option to colostomy in the management of obstructed defecation.

Entities:  

Mesh:

Year:  2002        PMID: 12004226     DOI: 10.1007/s10350-004-6273-2

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  4 in total

1.  Percutaneous endoscopic sigmoid colostomy for irrigation in the management of bowel dysfunction of adults with central neurologic disease.

Authors:  A Ramwell; M Rice-Oxley; A Bond; J N L Simson
Journal:  Surg Endosc       Date:  2011-06-03       Impact factor: 4.584

2.  Percutaneous endoscopic colostomy: A new technique for the treatment of recurrent sigmoid volvulus.

Authors:  Ibrahim K Al-Alawi
Journal:  Saudi J Gastroenterol       Date:  2010 Apr-Jun       Impact factor: 2.485

3.  Percutaneous endoscopic colostomy: a useful technique when surgery is not an option.

Authors:  Gloria Tun; Dominic Bullas; Ayman Bannaga; Elmuhtady M Said
Journal:  Ann Gastroenterol       Date:  2016-06-10

4.  Colonic irrigation for defecation disorders after dynamic graciloplasty.

Authors:  Sacha M Koch; Ozenç Uludağ; Kadri El Naggar; Wim G van Gemert; Cor G Baeten
Journal:  Int J Colorectal Dis       Date:  2007-09-21       Impact factor: 2.571

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.